Michael R. Ulrich, J.D., M.P.H.
doi : 10.1056/NEJMp2210269
Vol. 387 No. 14
Elizabeth Tobin-Tyler, J.D.
doi : 10.1056/NEJMp2209696
Elliott M. Antman, M.D., Jane A. Leopold, M.D., William H. Sauer, M.D., and Paul C. Zei, M.D., Ph.D.
doi : 10.1056/NEJMp2212526
Garen J. Wintemute, M.D., M.P.H., Daniel Müller, M.A., and Kyle Bolstad, B.A.
doi : 10.1056/NEJMp2209472
Samir R. Kapadia, M.D., Raj Makkar, M.D., Martin Leon, M.D., Mohamed Abdel-Wahab, M.D., Thomas Waggoner, D.O., Steffen Massberg, M.D., Wolfgang Rottbauer, M.D., Ph.D., Samuel Horr, M.D., Lars Sondergaard, M.D., Juhana Karha, M.D., Robert Gooley, M.B., B.S., Ph.D., Lowell Satler, M.D.,
doi : 10.1056/NEJMoa2204961
Transcatheter aortic-valve replacement (TAVR) for the treatment of aortic stenosis can lead to embolization of debris. Capture of debris by devices that provide cerebral embolic protection (CEP) may reduce the risk of stroke.
Rohit Aggarwal, M.D., Christina Charles-Schoeman, M.D., Joachim Schessl, M.D., Zsuzsanna Bata-Csörgő, M.D., Dr.Sc., Mazen M. Dimachkie, M.D., Zoltan Griger, M.D., Ph.D., Sergey Moiseev, M.D., Chester Oddis, M.D., Elena Schiopu, M.D., Jiri Vencovský, M.D., Dr.Sc., Irene Beckmann, Elisabeth Clodi, Ph.D.,
doi : 10.1056/NEJMoa2117912
Intravenous immune globulin (IVIG) for the treatment of dermatomyositis has not been extensively evaluated.
Spyros Chalkias, M.D., Charles Harper, M.D., Keith Vrbicky, M.D., Stephen R. Walsh, M.D., Brandon Essink, M.D., Adam Brosz, M.D., Nichole McGhee, B.S., Joanne E. Tomassini, Ph.D., Xing Chen, Sc.D., Ying Chang, M.S., Andrea Sutherland, M.D., M.P.H., David C. Montefiori, Ph.D.,
doi : 10.1056/NEJMoa2208343
The safety and immunogenicity of the bivalent omicron-containing mRNA-1273.214 booster vaccine are not known.
Paul Friedman, M.D., Francis Murgatroyd, F.R.C.P., Lucas V.A. Boersma, M.D., Ph.D., Jaimie Manlucu, M.D., David O’Donnell, M.B., B.S., Bradley P. Knight, M.D., Nicolas Clémenty, M.D., Ph.D., Christophe Leclercq, M.D., Ph.D., Anish Amin, M.D., Béla P. Merkely, M.D., Ph.D., D.Sc., Ulrika M. Birgersdotter-Green, M.D., Joseph Y.S. Chan, M.B., B.S.,
doi : 10.1056/NEJMoa2206485
The extravascular implantable cardioverter–defibrillator (ICD) has a single lead implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and defibrillation energy similar to that of transvenous ICDs. The safety and efficacy of extravascular ICDs are not yet known.
Deborah C. Girasek, Ph.D., M.P.H., and Stephen Hargarten, M.D., M.P.H.
doi : 10.1056/NEJMra2202392
Sumanth K. Bandaru, M.D.
doi : 10.1056/NEJMicm2202891
Binod K. Khaitan, M.B., B.S., M.D., and Rhea Ahuja, M.B., B.S., M.D.
doi : 10.1056/NEJMicm2203401
Ryan A. Denu, M.D., Ph.D., Daniel H. Solomon, M.D., M.P.H., Richard N. Mitchell, M.D., Ph.D., Yee-Ping Sun, M.D., and Joseph Loscalzo, M.D., Ph.D.
doi : 10.1056/NEJMcps2206178
John D. Carroll, M.D., and Jeffrey L. Saver, M.D.
doi : 10.1056/NEJMe2210185
Anthony A. Amato, M.D.
doi : 10.1056/NEJMe2209117
Eric J. Rubin, M.D., Ph.D., Lindsey R. Baden, M.D., John N. Nkengasong, Ph.D., and Stephen Morrissey, Ph.D.
doi : 10.1056/NEJMe2213168
Mary E. Norton, M.D.
doi : 10.1056/NEJMcibr2209405
Charles E. Binkley, M.D., Joel Michael Reynolds, Ph.D., and Andrew Shuman, M.D.
doi : 10.1056/NEJMms2207408
doi : 10.1056/NEJMc2210546
doi : 10.1056/NEJMc2210093
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟